Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells

International Journal of Oncology

Volumn 38, Issue 3, 2011, Pages 733-744

  Gupta, Reshu ^a   Chetty, Chandramu ^a   Bhoopathi, Praveen ^a   Lakka, Sajani ^a   Mohanam, Sanjeeva ^a   Rao, Jasti S ^a   Dinh, Dzung H ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Angiogenesis; Apoptosis; Cell cycle; Epithelial mesenchymal transition; Hypoxia; uPA; uPAR

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; NERVE CELL ADHESION MOLECULE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN ZO1; TRANSCRIPTION FACTOR SNAIL; UROKINASE; UROKINASE RECEPTOR; UVOMORULIN; VIMENTIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CELL; CELL HYPOXIA; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL HYPOXIA; CELLS, CULTURED; CEREBELLAR NEOPLASMS; CHICK EMBRYO; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MEDULLOBLASTOMA; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PERIODICITY; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RNA, SMALL INTERFERING; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79952020999     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2010.883     Document Type: Article

References (30)

1. Giangaspero H, Bigner SH, Kleihues P, Pietsch T and Trojanowski JQ: Medulloblastoma. In: Tumours of the Nervous System (World Health Organisation Classification of Tumours). Kleihues P and Cavenee WK (eds). IARC Press, Lyon, pp129-137, 2000.
2. Gilbertson RJ: Medulloblastoma: signalling a change in treatment. Lancet Oncol 5: 209-218, 2004.
3. Akakura N, Kobayashi M, Horiuchi I, Suzuki A, Wang J, Chen J, Niizeki H, Kawamura K, Hosokawa M and Asaka M: Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res 61: 6548-6554, 2001. (Pubitemid 32783263)
4. Martinive P, Defresne F, Bouzin C, Saliez J, Lair F, Gregoire V, Michiels C, Dessy C and Feron O: Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. Cancer Res 66: 11736-11744, 2006. (Pubitemid 46094185)
5. Moeller BJ and Dewhirst MW: Raising the bar: how HIF-1 helps determine tumor radiosensitivity. Cell Cycle 3: 1107-1110, 2004. (Pubitemid 40268623)
6. Harrison L and Blackwell K: Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 9 (Supp. 5): S31-S40, 2004.
7. Thompson EW, Newgreen DF and Tarin D: Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65: 5991-5995, 2005.
8. Lester RD, Jo M, Montel V, Takimoto S and Gonias SL: uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J Cell Biol 178: 425-436, 2007. (Pubitemid 47196151)
9. Graham CH, Forsdike J, Fitzgerald CJ and Donald-Goodfellow S: Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 80: 617-623, 1999. (Pubitemid 29047530)
10. Rofstad EK, Rasmussen H, Galappathi K, Mathiesen B, Nilsen K and Graff BA: Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. Cancer Res 62: 1847-1853, 2002.
11. Lester RD, Jo M, Campana WM and Gonias SL: Erythropoietin promotes MCF-7 breast cancer cell migration by an ERK/mitogen-activated protein kinase-dependent pathway and is primarily responsible for the increase in migration observed in hypoxia. J Biol Chem 280: 39273-39277, 2005. (Pubitemid 41713881)
12. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S and Comoglio PM: Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3: 347-361, 2003.
13. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P and Semenza GL: Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 63: 1138-1143, 2003. (Pubitemid 36278449)
14. Zhang F, Tom CC, Kugler MC, Ching TT, Kreidberg JA, Wei Y and Chapman HA: Distinct ligand binding sites in integrin alpha3beta1 regulate matrix adhesion and cell-cell contact. J Cell Biol 163: 177-188, 2003. (Pubitemid 37271444)
15. Gondi CS, Lakka SS, Yanamandra N, Siddique K, Dinh DH, Olivero WC, Gujrati M and Rao JS: Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis. Oncogene 22: 5967-5975, 2003. (Pubitemid 37175875)
16. Rao JS, Bhoopathi P, Chetty C, Gujrati M and Lakka SS: Matrix metalloproteinase-9 short interfering RNA induced senescence resulting in inhibition of medulloblastoma growth via p16INK4 and mitogen-activated protein kinase pathway. Cancer Res 67: 4956-4964, 2007. (Pubitemid 46910204)
17. Graham, FL and Prevec L: Manipulation of adenovirus vectors. In: Methods in Molecular Biology. Murray E J (ed). The Humana Press, Clifton, NJ, pp109-127, 1991.
18. Grunert S, Jechlinger M and Beug H: Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 4: 657-665, 2003. (Pubitemid 36934968)
19. Zhou J, Schmid T, Schnitzer S and Brune B: Tumor hypoxia and cancer progression. Cancer Lett 237: 10-21, 2006.
20. Harris AL: Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47, 2002.
21. Wang GL, Jiang BH, Rue EA and Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
22. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ and Harris AL: The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157: 411-421, 2000. (Pubitemid 30626905)
23. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons JW: Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59: 5830-5835, 1999.
24. Tarin D, Thompson EW and Newgreen DF: The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 65: 5996-6000, 2005. (Pubitemid 40994379)
25. Imai T, Horiuchi A, Wang C, Oka K, Ohira S, Nikaido T and Konishi I: Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol 163: 1437-1447, 2003. (Pubitemid 37175091)
26. Blasi F and Carmeliet P: uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3: 932-943, 2002. (Pubitemid 35477371)
27. Jo M, Thomas KS, Marozkina N, Amin TJ, Silva CM, Parsons SJ and Gonias SL: Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator. J Biol Chem 280: 17449-17457, 2005. (Pubitemid 41389216)
28. Jo M, Thomas KS, O'Donnell DM and Gonias SL: Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor. J Biol Chem 278: 1642-1646, 2003. (Pubitemid 36801395)
29. Ossowski L and Aguirre-Ghiso JA: Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol 12: 613-620, 2000.
30. Larue L and Bellacosa A: Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene. 24: 7443-7454, 2005. (Pubitemid 41637984)